Removal of dental amalgam decreases anti-TPO and anti-Tg autoantibodies in patients with autoimmune thyroiditis

Neuroendocrinology Letters

Volumn 27, Issue SUPPL. 1, 2006, Pages 25-30

  Sterzl, Ivan ^a,b   Prochazkova, Jarmila ^a   Hrda, Pavlina ^a,b   Matucha, Petr ^b   Bartova, Jirina ^a   Stejskal, Vera ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

Author keywords

Amalgam replacement; Anti thyroglobulin autoantibodies; Anti thyroid peroxidase autoantibodies; Autoimmune thyroiditis; Heavy metals; Hypersensitivity; MELISA ; Mercury

Indexed keywords

DENTAL ALLOY; MERCURY; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY;

ALLERGIC REACTION; ALLERGY TEST; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE THYROIDITIS; CLINICAL ARTICLE; FEMALE; HEAVY METAL REMOVAL; HUMAN; LYMPHOCYTE TRANSFORMATION TEST; MEMORY LYMPHOCYTE IMMUNOSTIMULATION ASSAY; RISK FACTOR; TOOTH FILLING;

AUTOANTIBODIES; AUTOANTIGENS; DENTAL AMALGAM; FEMALE; HUMANS; HYPERSENSITIVITY; IODIDE PEROXIDASE; IRON-BINDING PROTEINS; LYMPHOCYTE ACTIVATION; MERCURY; THYROIDITIS, AUTOIMMUNE; TREATMENT OUTCOME;

EID: 33847632318     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ai J, Leonhardt JM, Heymann WR. Autoimmune thyroid diseases: etiology, pathogenesis, and dermatologic manifestations. J Am Acad Dermatol. 2003; 48 (5): 641-659; 660-662.
2. Ban Y, Davies TF, Greenberg DA, Concepcion ES, Tomer Y. The influence of human leucocyte antigen (HLA) genes on autoimmune thyroid disease (AITD): results of studies in HLA-DR3 positive AITD families. Clin Endocrinol (Oxf). 2002; 57 (1): 81-88.
3. Barregard L, Lindstedt G, Schutz A, Sallsten G. Endocrine function in mercury exposed chloralkali workers. Occup Environ Med. 1994; 51 (8): 536-540.
4. Bartova J, Prochazkova J, Kratka Z, Benetkova K, Venclikova Z, Sterzl I. Dental amalgam as one of the risk factors in autoimmune diseases. Neuro Endocrinol Lett. 2003; 24 (1-2): 65-67.
5. Bech K, Clemmensen O, Larsen JH, Bendixen G. Thyroid disease and Yersinia. Lancet. 1977; 1 (8020): 1060-1061.
6. Bech K, Larsen JH, Hansen JM, Nerup J. Letter: Yersinia enterocolitica infection and thyroid disorders. Lancet. 1974; 2 (7886): 951-952.
7. Bertalot G, Montresor G, Tampieri M, Spasiano A, Pedroni M, Milanesi B et al. Decrease in thyroid autoantibodies after eradication of Helicobacter pylori infection. Clin Endocrinol (Oxf). 2004; 61 (5): 650-652.
8. Bogner U, Schleusener H, Wall JR. Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease. J Clin Endocrinol Metab. 1984; 59 (4): 734-738.
9. de Luis DA, Varela C, de La Calle H, Canton R, de Argila CM, San Roman AL et al. Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J Clin Gastroenterol. 1998; 26 (4): 259-263.
10. Farid NR, Larsen B, Payne R, Noel EP, Sampson L. Polyglandular autoimmune disease and HLA. Tissue Antigens. 1980; 16 (1): 23-29.
11. Figura N, Di Cairano G, Lore F, Guarino E, Gragnoli A, Cataldo D et al. The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders. J Physiol Pharmacol. 1999; 50 (5): 817-826.
12. Gianani R, Sarvetnick N. Viruses, cytokines, antigens, and autoimmunity. Proc Natl Acad Sci U S A. 1996; 93 (6): 2257-2259.
13. Hrda P, Sterzl I, Matucha P, Korioth F, Kromminga A. HLA antigen expression in autoimmune endocrinopathies. Physiol Res. 2004; 53 (2): 191-197.
14. Hudecek R, Danersund A., Kinigalakis G., Lindvall A. Experience of Medical Odontological Treatment: Removal of Incompatible Dental Material (RID) in Patients with Intolerance of Dental Materials. In: ed. Amalgam and Health - New Perspective on Risks. Conference of Swedish Council for Planning and Coordination of Research; Stockholm, Sweden; 14 Nov, 1997
15. Ionescu G. Allergotoxische Einflüsse von Umveltschadstoffen bei Allergiekranken [(Allergotoxic effects of environmental toxins.) (In German with English abstract).]. Forsch Komplementärmed. 1995: 22-28.
16. Kawada J, Nishida M, Yoshimura Y, Mitani K. Effects of organic and inorganic mercurials on thyroidal functions. J Pharmacobiodyn. 1980; 3 (3): 149-159.
17. Lichtenberg H. Elimination of symptoms by removal of dental amalgam from mercury poisoned patients as compared with a control group of average patients. J Orthomol Med. 1993; 8: 145-148.
18. Lindqvist B, Mörnstad M. Effect of removing amalgam fillings from patients with diseases affecting the immune system. Med Sci. 1996; 24: 355-356.
19. Mariotti S, Martino E, Caturegli P. et al. Hyperthyroidism, iodine and autoimmunity. In: Drexhage HA DVJ, Wiersinga WM, ed. The thyroid gland, environment and autoimmunity. 896th ed.; Amsterdam: Elsevier Science Publisher; 1990, p. 183-190.
20. Kurt E. Muller, Elizabeth Valentine-Thon. Hypersensitivity to titanium: Clinical and laboratory evidence. Neuro Endocrinol Lett. 2006 Dec; 27(Suppl 1): 31-35.
21. Mutter J, Naumann J, Schneider R, Walach H, Haley B. Mercury and autism: accelerating evidence? Neuro Endocrinol Lett. 2005; 26(5):439-46.
22. Prochazkova J, Bartova J, Ivaskova E, Kupkova L, Sterzl I, Stejskal VD. HLA-association in patients with intolerance to mercury and other metals in dental materials. Dis Markers. 2000; 16 (3-4): 135-138.
23. Prochazkova J, Sterzl I, Kucerova H, Bartova J, Stejskal VD. The beneficial effect of amalgam replacement on health in patients with autoimmunity. Neuro Endocrinol Lett. 2004; 25 (3): 211-218.
24. Rowley B, Monestier M. Mechanisms of heavy metal-induced autoimmunity. Mol Immunol. 2005; 42 (7): 833-838.
25. Shitova O, Guseva L, Denisova A, Cebere I, Kork O. Immunosupression caused by industrial chemicals in workers of a pharmaceutical factory. In: ed. 8th International Congress of Immunology; August 1992; Budapest, Hungary: Springer Hungarica 1992, p. 597
26. Skare I, Bergstrom T, Engqvist A, Weiner JA. Mercury exposure of different origins among dentists and dental nurses. Scand J Work Environ Health. 1990; 16 (5): 340-347.
27. Stassi G, De Maria R. Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol. 2002; 2 (3): 195-204.
28. Stejskal V, Danersund A, Lindvall A, Hudecek R, Yaqob A, Lindh U. et al. Metal-specific lymphocytes: biomarkers of sensitivity in man. Neuro Endocrinol Lett. 1999: 221-228.
29. Stejskal V, Danersund A, Hudecek R, Lindvall A. MELISA-a new test for the diagnosis of mercury allergy. In: ed. International Conference on Human Health Effects of Mercury Exposure; Faroe Islands: Torshavn; June 22-26, 1997, p. 123-124
30. Stejskal VD, Forsbeck M, Cederbrant KE, Asteman O. Mercury-specific lymphocytes: an indication of mercury allergy in man. J Clin Immunol. 1996; 16 (1): 31-40.
31. Stejskal VD, Forsbeck M, Nilsson R. Lymphocyte transformation test for diagnosis of isothiazolinone allergy in man. J Invest Dermatol. 1990; 94 (6): 798-802.
32. Stejskal VDM. Allergy to drugs and other chemicals diagnosed by the presence of specific memory cells in human blood. In: Ivanyi P, ed. Realm of tolerance; New York, London, Tokyo: Springer Verlag; 1989, p. 213-225.
33. Stejskal VDM, Cederbrant K, Lindvall A, Forsbeck M. MELISA - an in vitro tool for the study of metal allergy. Toxicol In Vitro. 1994; 5: 991-1000.
34. Stejskal VDM, Olin RG, Forsbeck M. The lymphocyte transformation test for diagnosis of drug-induced occupation allergy. J Allergy Clin Immunol. 1986; 77: 411-426.
35. Stejskal VD, Hudecek R, Stejskal J, Sterzl I. Diagnosis and treatment of metal-induced side-effects. Neuro Endocrinol Lett. 2006 Dec; 27(Suppl 1): 7-16.
36. Sterzl I, Hrda P, Prochazkova J, Bartova J, Matucha P. [Reactions to metals in patients with chronic fatigue and autoimmune endocrinopathy (In Czech with English abstract).]. Vnitr Lek. 1999; 45 (9): 527-531.
37. Sterzl I, Prochazkova J, Hrda P, Bartova J, Matucha P, Stejskal VD. Mercury and nickel allergy: risk factors in fatigue and autoimmunity. Neuro Endocrinol Lett. 1999; 20 (3-4): 221-228.
38. Valentine-Thon E, Muller KE, Guzzi G, Kreisel S, Ohnsorge P, Sandkamp M. LTT-MELISA® is clinically relevant for detecting and monitoring metal sensitivity. Neuro Endocrinol Lett. 2006 Dec; 27(Suppl 1): 17-24.
39. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995; 43 (1): 55-68.
40. Zamm AV. Removal of dental mercury often an effective treatment for the very sensitive patient. J Orthomol Med. 1990; 5: 138-142.